Health Care Technology
Company Overview of Preventice Inc.
Preventice Inc. develops mobile health applications and patient monitoring systems that connect mobile, home-based, and on-premise technologies for continuous patient care. It offers HealthClips Rx, an interactive patient education platform that feeds data about patient compliance and post-surgical complications back into the clinical system; and CARD-Contact Allergen Replacement Database, which provides people with skin allergies access to information about products that contain known allergens. The company also provides Coppertone MyUVAlert that helps people avoid overexposure to the sun; and iManage Migraine, an application that helps people to track and understand what triggers their mig...
1652 Greenview Drive SW
Rochester, MN 55902
Founded in 2007
Key Executives for Preventice Inc.
Co-founder and Software Engineer
Co-founder and Life Science Program Manager
Co-founder and Vice President of Technology Solutions
Compensation as of Fiscal Year 2013.
Preventice Inc. Key Developments
Preventice(R), Inc. Hires Kevin Nickels as Chief Operating Officer
Oct 29 13
Preventice(R) Inc. announced that Kevin Nickels has joined the company as chief operating officer. Nickels brings nearly 40 years experience in product and business development; general management; and an ability to raise and monetize invested capital - 26 of which were spent at medical device companies - to his new role at the company. He will be responsible for leading the global market expansion of the BodyGuardian(R) Remote Monitoring System (BodyGuardian) and for continuing to evolve and enhance operations for the company's remote monitoring solutions. Prior to joining the company, Nickels was president and CEO of CytoPherx Inc. Prior to CytoPherx, Nickels was president and CEO of Rubigo Technologies Inc.; chairman of Advanced Vein Therapy Inc.; president and CEO of Celleration Inc.; and president and CEO of Kinesis Medical. Before entering the medical device industry in 1997, Nickels was a business unit leader for Rosemount Aerospace where he led and acquired multiple business units.
Preventice, Inc. Enhances Arrhythmia Classification Capabilities of its BodyGuardian Remote Monitoring System
Oct 17 13
Preventice Inc. announced it has enhanced the ability of its BodyGuardian Remote Monitoring System to identify anomalous ECG rhythms and will now provide greater precision in identifying the type of arrhythmias that occurred when reporting events to care teams. The new capability supports the clinical scalability of BodyGuardian by increasing clinician efficiency as identified events are reviewed to confirm arrhythmia classifications. The company has improved on the original diagnostic powers of the BodyGuardian by increasing from five to 22, the number of classifications for ECG selection and arrhythmia analysis. The original five classification algorithms are licensed from Mayo Clinic. The additional classifications are also derived from proven algorithms and increase the precision of the event description that is delivered to the physician a key system advantage is that BodyGuardian provides a wider context of the patient's biometric data for the physician to review with events. With each event, the physician receives trend data for key biometrics including respiratory rate, heart rate and activity rate. This allows the physician to review a targeted set of patient data to better understand event circumstances and the patient's condition in total, as they diagnose and develop the patient's care plan. Additionally, the latest release deploys user interface updates to the care team portal that are derived from the ongoing communication and learning with customers. This includes updates that allow clinicians to leverage the added classification support and streamline the ECG review process; default user and navigation preference improvements; deployment of additional user filtering capabilities; and finally, workflow optimizations that minimize the steps needed to review individual events.
Preventice Inc. Announces Commercial Availability of BodyGuardian Remote Patient Monitoring System(TM)
May 10 13
Preventice Inc. announced the commercial availability of its BodyGuardian Remote Patient Monitoring System (BodyGuardian RMS). Preventice received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in August 2012, enabling the mobile health solutions company to market BodyGuardian for use in detecting and monitoring non-lethal cardiac arrhythmias for ambulatory patients. Developed in collaboration with Mayo Clinic, the BodyGuardian System uses sophisticated algorithms to support remote monitoring for individuals with cardiac arrhythmias. The BodyGuardian System allows physicians to monitor key biometrics outside of the clinical setting, while patients go about their daily lives. A small body sensor to the patient's chest collects important data, including ECG, heart rate, respiration rate, and activity level. Patient data can then be transmitted to physicians via mobile phone technology. This level of remote patient monitoring can create a constant connection between patients and their care teams. Remote patient monitoring can aid in the diagnosis of atrial fibrillation by providing accessible ECG and rhythm monitoring in both symptomatic and asymptomatic people as they go about their daily lives. The technology can also support treatment efforts by allowing physicians to screen for high-risk atrial fibrillation patients, to validate treatment, show medication compliance, and monitor patients who are adjusting to anticoagulation medication. While the cost for treating atrial fibrillation--including hospitalization, in- and out-patient physician care and medications--grew to $6.65 billion in 2005, the use of remote monitoring technology by leading health care organizations has been steadily on the rise and is expected to continue its upward trajectory.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|